A nuclear threat spurs France’s Medisis to advance radiation therapy

Listen to the article 8 min This audio is auto-generated. Please let us know if you have feedback. The Russian invasion of Ukraine has elevated fears of a nuclear threat, prompting many to ask the question: “What if?” Medisis Pharma’s Marc Bigret Permission granted by Medisis/Marc Bigret Unfortunately, the answer is sobering. Currently, no post-radiation … Read more